Joseph T. Kennedy, VP and General Counsel at Transcept Pharmaceuticals Inc (TSPT), sold 60,816 shares at $8.23 ($501K) on 2011-12-01, disclosed to the SEC on 2011-12-05.
Scheduled sale ($501k) by VP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.23 | 4,150 | $34K | 6.8% |
| 2 | $8.23 | 56,666 | $466K | 93.2% |
| Total | $8.23 avg | 60,816 | $501K | 100% |
| Filing → |
| AMRN | SELL | 2019-05-02 | $509K | — | Filing → |
| AMRN | SELL | 2019-04-01 | $1.1M | — | Filing → |
| AMRN | SELL | 2019-03-01 | $1.1M | — | Filing → |